Company Profiles

driven by the PitchBook Platform

Ashvattha Therapeutics

2015 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$37.4K LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of nano therapies for cerebral palsy. The company develops multiple novel therapies for the treatment of orphan pediatric brain disorders.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 303 Twin Dolphin Drive
  • Suite 600
  • Redwood City, CA 94065
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ashvattha Therapeutics’s full profile, request a free trial.

Ashvattha Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 01-Jun-2016 $37.4K 00000 Completed Startup
1. Angel (individual) 03-Mar-2016 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Ashvattha Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Fast Forward at Johns Hopkins University Accelerator/Incubator 000 0000 000000 0

Ashvattha Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
Jeffrey Cleland Co-Founder, Executive Chairman and President
Kannan Rangaramanujam Ph.D Co-Founder and Chief Technology Officer
Justin Hanes Ph.D Co-Founder